Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Breast Cancer Research and Treatment|March 1, 1997
Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective studyD Amadori, A Volpi, R Maltoni, et al.
Breast (Edinburgh, Scotland)|August 2, 2005
Atypical ductal hyperplasia of the breast: the controversial management of a borderline lesion: experience of 47 cases diagnosed at vacuum-assisted biopsyL Bedei, F Falcini, P A Sanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasoneF Roila, M Tonato, F Cognetti, et al.
Seminars in Oncology|November 28, 1997
Paclitaxel plus doxorubicin in breast cancer: an Italian experienceG L Frassineti, W Zoli, L Silvestro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Steroid receptor enhancement by natural interferon-beta in advanced breast cancerG Sica, F Iacopino, G Lama, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical resultsP F Conte, G Gardin, P Pronzato, et al.
International Journal of Cancer|January 17, 1995
Oral contraceptives and breast cancer: a cooperative Italian studyC La Vecchia, E Negri, S Franceschi, et al.
Tumori|June 30, 1986
Breast cancer risk factors in Italian women: a multicentric case-control studyA Toti, S Agugiaro, D Amadori, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1991
Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer riskD Palli, A Decarli, F Cipriani, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patientsR Ridolfi, E Flamini, A Riccobon, et al.
Pageof 17